These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 23816060)

  • 1. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antidepressant hyperforin increases the phosphorylation of CREB and the expression of TrkB in a tissue-specific manner.
    Gibon J; Deloulme JC; Chevallier T; Ladevèze E; Abrous DN; Bouron A
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):189-98. PubMed ID: 22226089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria.
    Tu P; Gibon J; Bouron A
    J Neurochem; 2010 Jan; 112(1):204-13. PubMed ID: 19845832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular neurobiology of hyperforin.
    Bouron A
    Phytother Res; 2024 Feb; 38(2):636-645. PubMed ID: 37963759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
    Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
    Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPC6 channel-mediated neurite outgrowth in PC12 cells and hippocampal neurons involves activation of RAS/MEK/ERK, PI3K, and CAMKIV signaling.
    Heiser JH; Schuwald AM; Sillani G; Ye L; Müller WE; Leuner K
    J Neurochem; 2013 Nov; 127(3):303-13. PubMed ID: 23875811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
    Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
    FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels.
    Leuner K; Li W; Amaral MD; Rudolph S; Calfa G; Schuwald AM; Harteneck C; Inoue T; Pozzo-Miller L
    Hippocampus; 2013 Jan; 23(1):40-52. PubMed ID: 22815087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
    Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
    Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
    Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
    Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hyperforin in the pharmacological activities of St. John's Wort.
    Zanoli P
    CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility.
    Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA
    J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
    Wurglics M; Schubert-Zsilavecz M
    Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple 2,4-diacylphloroglucinols as classic transient receptor potential-6 activators--identification of a novel pharmacophore.
    Leuner K; Heiser JH; Derksen S; Mladenov MI; Fehske CJ; Schubert R; Gollasch M; Schneider G; Harteneck C; Chatterjee SS; Müller WE
    Mol Pharmacol; 2010 Mar; 77(3):368-77. PubMed ID: 20008516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Biochemical and Genetic Basis for the Biosynthesis of Bioactive Compounds in
    Rizzo P; Altschmied L; Ravindran BM; Rutten T; D'Auria JC
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33081197
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs.
    Butterweck V; Nahrstedt A; Evans J; Hufeisen S; Rauser L; Savage J; Popadak B; Ernsberger P; Roth BL
    Psychopharmacology (Berl); 2002 Jul; 162(2):193-202. PubMed ID: 12110997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.